Financhill
Back

Compass Therapeutics, Inc. 10K Form

Buy
55

CMPX
Compass Therapeutics, Inc.

Last Price:
$5.36
Seasonality Move:
2.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CMPX News And Ratings

See the #1 stock for the next 7 days that we like better than CMPX

CMPX Financial Statistics

Sales & Book Value

Annual Sales: $850K
Cash Flow: $-10.9M
Price / Cash Flow: 0
Annual Sales: $1.18
Price / Book: 4.69

Profitability

EPS (TTM): -0.45760
Net Income (TTM): $-65.8M
Gross Margin: $-903K
Return on Equity: -48.62%
Return on Assets: -42.79%

Compass Therapeutics, Inc. Earnings Forecast

Key Compass Therapeutics, Inc. Financial Ratios

  • The Gross Profit Margin over the past 7 years for CMPX is -106.24%.
  • The Selling, General & Administrative Expenses for CMPX have been equal to 1,780.35% of Gross Profit Margin.
  • The Research & Development expenses have been 4,912.12% of Revenue.
  • The Net Earning history of CMPX is -5,808.82% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Compass Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CMPX
Website: compasstherapeutics.com

Debt

Debt-to-Equity Ratio: 0.05
Current Ratio: 17.82
Quick Ratio: 17.72

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CMPX Technical Analysis vs Fundamental Analysis

Buy
55
Compass Therapeutics, Inc. (CMPX) is a Buy

Is Compass Therapeutics, Inc. a Buy or a Sell?